Natarajan Sethuraman Entrada Therapeutics, Inc. (TRDA) insider trading activity

TRDA Quotes by TradingView

Natarajan Sethuraman is President, Research & Develop. of Entrada Therapeutics, Inc.. Currently has a direct ownership of 144,997 shares of TRDA, which is worth approximately $2.12 Million. The most recent transaction as insider was on Jul 10, 2023, when has been sold 3,026 shares (Common Stock) at a price of $18.0 per share, resulting in proceeds of $54,468. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 145K
21.12% 3M change
13.28% 12M change
Total Value Held $2.12 Million

Natarajan Sethuraman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 10 2023
SELL
Open market or private sale
$54,468 $18.0 p/Share
3,026 Reduced 1.77%
168,299 Common Stock
Apr 17 2023
SELL
Open market or private sale
$71,298 $18.0 p/Share
3,961 Reduced 2.26%
171,325 Common Stock
Mar 02 2023
SELL
Payment of exercise price or tax liability
$12,272 $11.6 p/Share
1,058 Reduced 0.56%
189,486 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
28,400 Added 12.97%
190,544 Common Stock
Sep 01 2022
BUY
Grant, award, or other acquisition
-
5,794 Added 3.45%
162,144 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
11,588 Added 6.9%
156,350 Common Stock
NS

Natarajan Sethuraman

President, Research & Develop.
Boston, MA

Track Institutional and Insider Activities on TRDA

Follow Entrada Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRDA shares.

Notify only if

Insider Trading

Get notified when an Entrada Therapeutics, Inc. insider buys or sells TRDA shares.

Notify only if

News

Receive news related to Entrada Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TRDA